Severe thrombotic and bleeding complications in a baby with heterozygous factor V Leiden and acquired von Willebrand disease on ECMO

Journal of Extra-Corporeal Technology

Volumn 43, Issue 2, 2011, Pages 64-69

  Bilen, Ozlem ^a   Loftis, Laura ^a   Teruya, Jun ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Acquired von Willebrand disease; Anticoagulation; Coagulation; Extracorporeal membran oxygenation; Factor V Leiden; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN; NITRIC OXIDE;

ARTICLE; CARDIOPULMONARY ARREST; CASE REPORT; COUGHING; DISEASE SEVERITY; DOPPLER FLOWMETRY; DRUG DOSE ESCALATION; DRUG MEGADOSE; EXTRACORPOREAL OXYGENATION; FEMALE; FEVER; HEART RIGHT VENTRICLE FAILURE; HEMOLYSIS; HETEROZYGOSITY; HIGH FREQUENCY VENTILATION; HUMAN; INFANT; LEG SWELLING; LEG THROMBOSIS; LUNG HEMORRHAGE; PLASMAPHERESIS; PURPURIC RASH; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RHINORRHEA; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; VON WILLEBRAND DISEASE;

EID: 79961236796     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sivarajan VB, Best D, Brizard CP, et al. Improved outcomes of pediatric extracorporeal support associated with technology change. Interact Cardiovasc Thorac Surg. 2010;10:400-5.
2. Villagra J, Shiva S, Hunter LA, et al. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood. 2007; 110:2166-72.
3. McILwain RB, Timpa JG, Kurundkar AR, et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest. 2010;90:128-39.
4. Shanberge JN, Quattrociocchi-Longe TM. Influence of platelet factor 4 on the neutralization of heparin by protamine. Ann N Y Acad Sci. 1989;556:354-65.
5. Rother RP, Bell L, Hillmen P, et al. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA. 2005;293:1653-62.
6. Toomasian JM, Bartlett RH. Hemolysis and ECMO pumps in the 21st century. Perfusion. 2011;26:5-6.
7. Baxter PA, Nuchtern JG, Guillerman RP, et al. Acquired von Willebrand syndrome and Wilms tumor: Not always benign. Pediatr Blood Cancer. 2009;52:392-4.
8. Uriel N, Pak SW, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56:1207-13.
9. Aschka I, Aumann V, Bergmann F, et al. Prevalence of factor V Leiden in children with thrombo-embolism. Eur J Pediatr. 1996;155:1009-14.
10. Mattson JC, Crisan D. Inherited thrombophilia due to factor V Leiden mutation. Mol Diagn. 1998;3:55-61.
11. Agorastos T, Karavida A, Lambropoulos A, et al. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. J Matern Fetal Neonatal Med. 2002;12:267-73.
12. Del Balzo F, Spalice A, Ruggieri M, et al. Stroke in children: Inherited and acquired factors and age-related variations in the presentation of 48 paediatric patients. Acta Paediatr. 2009;98:1130-6 [Epub April 30, 2009].
13. Khaja WA, Bilen O, Lukner RB, et al. Evaluation of heparin assay for coagulation management in newborns undergoing ECMO. Am J Clin Pathol. 2010;134:950-4.